lirentelimab (AK002) - Allakos
ligelizumab (QGE 031) - Novartis
Xolair (omalizumab) - Roche, Novartis
fenebrutinib (GDC-0853) - Roche
AZD1981 - AstraZeneca
GSK2646264 - GSK
http://www.ncbi.nlm.nih.gov/pubmed/31494233
 
Sep 9, 2019
 
Prev Next